Nevro Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Nevro Corp. (NYSE: NVRO), a leader in chronic pain treatment, has announced its participation in three significant investor conferences in May 2023. On May 10, CEO Kevin Thornal and CFO Rod MacLeod will present at the Bank of America 2023 Health Care Conference in Las Vegas at 5:00 pm PT. Following this, Rod MacLeod will present on May 16 at the JMP Securities Life Sciences Conference in New York at 11:00 am ET, and again on May 17 at the RBC Capital Markets Global Healthcare Conference at 11:30 am ET. Interested investors can access live webcasts and archived recordings from the events via Nevro's website. Nevro specializes in delivering innovative solutions for chronic pain, including the proprietary 10 kHz Therapy™ that benefits over 100,000 patients globally.

REDWOOD CITY, Calif., April 24, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that it is participating in the following investor conferences:

• On May 10, 2023, Kevin Thornal, CEO & President, and Rod MacLeod, Chief Financial Officer, will present at the Bank of America 2023 Health Care Conference at 5:00 pm Pacific Time at the Encore at the Wynn Hotel in Las Vegas, NV.
• On May 16, 2023, Rod MacLeod, Chief Financial Officer, will present at the JMP Securities Life Sciences Conference at 11:00 am Eastern Time at the New York Hilton Midtown Hotel in New York, NY.
• On May 17, 2023, Rod MacLeod, Chief Financial Officer, will present at the 2023 RBC Capital Markets Global Healthcare Conference at 11:30 am Eastern Time at the InterContinental Barclay Hotel in New York, NY.

A webcast for these events, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com.

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com. The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 100,000 patients globally. Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes a Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. 

Senza^®, Senza II^®, Senza Omnia™, and HFX iQ™ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy™. Nevro's unique support services provide every patient with an HFX Coach™ throughout their pain relief journey and every physician with HFX Cloud™ insights for enhanced patient and practice management.

SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Chief Corp Communications and Investor Relations Officer
650-433-3247  |  julie.dewey@nevro.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-announces-participation-in-upcoming-investor-conferences-301804880.html

SOURCE Nevro Corp.

FAQ

What events is Nevro participating in during May 2023?

Nevro is participating in three investor conferences: the Bank of America 2023 Health Care Conference on May 10, the JMP Securities Life Sciences Conference on May 16, and the RBC Capital Markets Global Healthcare Conference on May 17.

Who from Nevro will present at the Bank of America Health Care Conference?

Kevin Thornal, CEO, and Rod MacLeod, CFO, will present at the Bank of America Health Care Conference on May 10, 2023.

When is Nevro's presentation at the JMP Securities Life Sciences Conference?

Rod MacLeod, CFO of Nevro, will present at the JMP Securities Life Sciences Conference on May 16, 2023, at 11:00 am ET.

What time is Nevro's presentation at the RBC Capital Markets Global Healthcare Conference?

Rod MacLeod, CFO of Nevro, will present at the RBC Capital Markets Global Healthcare Conference on May 17, 2023, at 11:30 am ET.

Where can I find the webcast for Nevro's investor presentations?

The webcasts and archived recordings of Nevro's investor presentations will be available in the Investors section of Nevro's website.